Hyperimmune immunoglobulin does not improve outcomes in patients hospitalized with COVID-19
1. Hyperimmune intravenous immunoglobulin (hIVIG) did not increase odds of better outcomes in patients with COVID-19 compared to placebo. 2. ...
1. Hyperimmune intravenous immunoglobulin (hIVIG) did not increase odds of better outcomes in patients with COVID-19 compared to placebo. 2. ...
5-day free trial · cancel anytime
Then $4.99/month. Manage renewal in your account.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
Monthly plan selected: $4.99 /month.
5-day free trial · cancel anytime
Then $4.99/month. Manage renewal in your account.
Yearly plan selected: $49.90 /year.
2 months free · only $4.16/month
Then $49.90/year. Manage renewal in your account.
Already a member? Sign in